Safety study of repeat doses of FX006 in patients with osteoarthritis
Phase of Trial: Phase II
Latest Information Update: 10 Mar 2016
At a glance
- Drugs Triamcinolone (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- 10 Mar 2016 Planned initiation date changed from 1 Jun 2014 to 1 Apr 2016, as reported by Flexion media release.
- 10 Mar 2016 According to Flexion media release, this trial is expected to initiate in 2016.
- 07 May 2015 New trial record